0382

· MedImmune LLC

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for 0382, covering 2019-11-19 to 2022-05-31. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate Safety and Pharmacodynamic Efficacy of 0382 in Obese Subjects With NAFLD/NASH. [Phase 2]